Recent Advances in Light-Controlled Activation of Pt(IV) Prodrugs

Pt(IV) prodrugs remain one of the most promising alternatives to conventional Pt(II) therapy due to their versatility in axial ligand choice and delayed mode of action. Selective activation from an external source is especially attractive due to the opportunity to control the activity of an antitumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Spector, Daniil, Pavlov, Kirill, Beloglazkina, Elena, Krasnovskaya, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739791/
https://www.ncbi.nlm.nih.gov/pubmed/36498837
http://dx.doi.org/10.3390/ijms232314511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739791/
https://www.ncbi.nlm.nih.gov/pubmed/36498837
http://dx.doi.org/10.3390/ijms232314511

Ejemplares similares